The SCAP/SREBP/INSIG1 trio promotes hepatic lipid remodeling to protect the liver from lipotoxic insults associated with the progression of nonalcoholic steatohepatitis progression [63]. The gene discussed is SCAP; the disease is metabolic dysfunction-associated steatohepatitis.